Therapy: Off-label biologics use and infection risk-the great unknown

Kevin Winthrop, Josef S. Smolen

Research output: Contribution to journalArticle

1 Citation (Scopus)
Original languageEnglish (US)
Pages (from-to)685-686
Number of pages2
JournalNature Reviews Rheumatology
Volume7
Issue number12
DOIs
StatePublished - Dec 2011

Fingerprint

Off-Label Use
Immunologic Factors
Biological Products
Autoimmune Diseases
Infection
Therapeutics

ASJC Scopus subject areas

  • Rheumatology

Cite this

Therapy : Off-label biologics use and infection risk-the great unknown. / Winthrop, Kevin; Smolen, Josef S.

In: Nature Reviews Rheumatology, Vol. 7, No. 12, 12.2011, p. 685-686.

Research output: Contribution to journalArticle

@article{0c8e571c4cd640c2b7aa1fae75369f1f,
title = "Therapy: Off-label biologics use and infection risk-the great unknown",
author = "Kevin Winthrop and Smolen, {Josef S.}",
year = "2011",
month = "12",
doi = "10.1038/nrrheum.2011.154",
language = "English (US)",
volume = "7",
pages = "685--686",
journal = "Nature Reviews Rheumatology",
issn = "1759-4790",
publisher = "Nature Publishing Group",
number = "12",

}

TY - JOUR

T1 - Therapy

T2 - Off-label biologics use and infection risk-the great unknown

AU - Winthrop, Kevin

AU - Smolen, Josef S.

PY - 2011/12

Y1 - 2011/12

UR - http://www.scopus.com/inward/record.url?scp=82955249018&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82955249018&partnerID=8YFLogxK

U2 - 10.1038/nrrheum.2011.154

DO - 10.1038/nrrheum.2011.154

M3 - Article

C2 - 21989283

AN - SCOPUS:82955249018

VL - 7

SP - 685

EP - 686

JO - Nature Reviews Rheumatology

JF - Nature Reviews Rheumatology

SN - 1759-4790

IS - 12

ER -